Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.14 trillion and total revenue of $112.35 billion.
Market Cap
1.14T
Revenue
112.35B
Profits
-39.93B
PE Ratio
n/a
Profit Margin
-35.54%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.24B | -0.28% | 209,660 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.75B | -0.83% | 110,732 | 14.92B |
| 3 | ARGX | argenx SE | 50.31B | -2.17% | 262,347 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.81B | -1.59% | 288,154 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.59B | -0.71% | 87,067 | 5.74B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.58B | -4.77% | 709,926 | - |
| 7 | RPRX | Royalty Pharma plc | 29.39B | -2.25% | 1,455,136 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.86B | -19.36% | 4,846,614 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.70B | -1.64% | 477,325 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.38B | -1.20% | 654,906 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.62B | -1.63% | 224,759 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.23B | -0.66% | 4,089,725 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.09B | -1.94% | 2,055,554 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.57B | -0.01% | 541,907 | 845.52M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.12B | -1.56% | 301,609 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.55B | -2.18% | 825,741 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.36B | 0.22% | 717,344 | 502.08M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.54B | -1.25% | 195,392 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.05B | -3.18% | 82,922 | 1.13B |
| 20 | EXEL | Exelixis, Inc. | 11.79B | -4.66% | 929,943 | 2.38B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.24B | -1.86% | 174,062 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.79B | -2.65% | 631,000 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.42B | -1.30% | 470,888 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 10.26B | 0.62% | 419,970 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.30B | -0.12% | 4,159,410 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.12B | -3.14% | 147,929 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.34B | -2.07% | 49,419 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 8.11B | -1.50% | 117,280 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.09B | -6.56% | 7,392,574 | 140.98M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.72B | -1.78% | 280,214 | 1.40B |
| 31 | TECH | Bio-Techne Corporation | 7.56B | 1.87% | 1,368,426 | 1.21B |
| 32 | PCVX | Vaxcyte, Inc. | 7.53B | -8.72% | 2,451,531 | - |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.09B | -0.07% | 3,740 | 51.48M |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.51B | -1.69% | 167,537 | 217.17M |
| 35 | TGTX | TG Therapeutics, Inc. | 6.36B | 2.60% | 1,494,065 | 700.35M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.36B | -4.92% | 216,473 | 74.06M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.35B | 0.18% | 8,340 | - |
| 38 | CELC | Celcuity Inc. | 6.28B | -6.78% | 447,236 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 6.21B | -7.46% | 904,875 | 569.61M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.18B | -2.07% | 63,830 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.13% | 597,277 | 15.00M |
| 42 | CGON | CG Oncology, Inc. | 6.07B | 1.34% | 173,134 | 4.04M |
| 43 | BLTE | Belite Bio, Inc | 6.06B | -1.42% | 156 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 5.95B | -2.98% | 700,585 | - |
| 45 | IMVT | Immunovant, Inc. | 5.70B | -2.30% | 148,696 | - |
| 46 | CAI | Caris Life Sciences, Inc. | 5.55B | 2.56% | 723,503 | 812.03M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.54B | -2.23% | 88,907 | 7.50M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.49B | -2.38% | 306,749 | - |
| 49 | CORT | Corcept Therapeutics Incorporated | 5.47B | -2.21% | 189,287 | 769.10M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.40B | -2.17% | 139,251 | 1.73B |
| 51 | LEGN | Legend Biotech Corporation | 5.32B | -0.69% | 461,818 | 1.03B |
| 52 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.17% | 1,535,236 | 1.00B |
| 53 | CRSP | CRISPR Therapeutics AG | 5.15B | -3.07% | 484,096 | 4.10M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.73B | -4.30% | 23,157 | 1.34M |
| 55 | MANE | Veradermics, Incorporated | 4.60B | 1.72% | 130,659 | - |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.31B | -1.34% | 250,891 | 7.70M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.26B | -8.62% | 230,947 | 274.48M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.09B | -1.68% | 6,303,314 | 536.20M |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 3.87B | -2.68% | 214,109 | - |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.85B | -7.73% | 634,384 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | 3.63% | 1,073,711 | 1.10B |
| 62 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 2.11% | 8,414,758 | 588.99M |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.72B | 4.45% | 609,627 | 22.50M |
| 64 | TLX | Telix Pharmaceuticals Limited | 3.70B | -3.15% | 86,856 | 803.79M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.63B | -3.19% | 493,419 | - |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.37B | -1.06% | 853,821 | 62.38M |
| 67 | ERAS | Erasca, Inc. | 3.19B | -5.78% | 2,019,266 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.19B | -2.38% | 153,040 | 236.00M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.16B | -2.60% | 642,853 | 164.01M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.15B | -2.79% | 343,670 | - |
| 71 | ALMS | Alumis Inc. | 3.13B | -3.45% | 234,412 | 24.05M |
| 72 | KLRA | Kailera Therapeutics, Inc. | 3.01B | -6.07% | 69,802 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.94B | -5.63% | 396,101 | - |
| 74 | NKTR | Nektar Therapeutics | 2.82B | -1.82% | 9,461 | 55.23M |
| 75 | GPCR | Structure Therapeutics Inc. | 2.80B | -3.55% | 302,268 | - |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 2.75B | -8.98% | 1,559,648 | 415.62M |
| 77 | KOD | Kodiak Sciences Inc. | 2.75B | -3.57% | 93,553 | - |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.74B | -0.02% | 999,547 | 190.41M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 2.64B | -2.01% | 223,494 | 1.55M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -5.71% | 418,895 | 535.08M |
| 81 | IRON | Disc Medicine, Inc. | 2.57B | -2.00% | 76,661 | - |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 0.54% | 443,556 | 670.00M |
| 83 | IMNM | Immunome, Inc. | 2.55B | -3.39% | 137,634 | 6.94M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.52B | -3.84% | 183,215 | - |
| 85 | DFTX | Definium Therapeutics, Inc. | 2.50B | -1.96% | 357,934 | - |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | -1.36% | 107,649 | 225.27M |
| 87 | ELVN | Enliven Therapeutics, Inc. | 2.45B | -2.18% | 114,866 | - |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | -1.86% | 355,891 | - |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.40B | -3.17% | 484,581 | 10.68M |
| 90 | ZLAB | Zai Lab Limited | 2.19B | -7.38% | 390,191 | 460.16M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.15B | -11.68% | 2,356,690 | 2.18B |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.14B | 0.82% | 725,969 | 52.04M |
| 93 | AAPG | Ascentage Pharma Group International | 2.06B | 2.04% | 3 | 82.08M |
| 94 | STOK | Stoke Therapeutics, Inc. | 2.03B | -2.19% | 94,045 | 184.42M |
| 95 | NBTX | Nanobiotix S.A. | 1.98B | 3.97% | 66,533 | 38.27M |
| 96 | TYRA | Tyra Biosciences, Inc. | 1.98B | -1.73% | 124,610 | - |
| 97 | ZYME | Zymeworks Inc. | 1.97B | -3.15% | 5,055 | 105.97M |
| 98 | SION | Sionna Therapeutics, Inc. | 1.96B | 0.30% | 120,233 | - |
| 99 | MESO | Mesoblast Limited | 1.96B | -4.68% | 61,815 | 65.38M |
| 100 | PHVS | Pharvaris N.V. | 1.96B | -0.70% | 50,041 | - |
| 101 | ADMA | ADMA Biologics, Inc. | 1.96B | -16.52% | 11,548,902 | 509.86M |
| 102 | CAPR | Capricor Therapeutics, Inc. | 1.94B | -2.59% | 196,750 | 11.13M |
| 103 | TRVI | Trevi Therapeutics, Inc. | 1.94B | -4.42% | 676,132 | - |
| 104 | INBX | Inhibrx Biosciences, Inc. | 1.93B | -7.08% | 124,649 | 1.30M |
| 105 | TSHA | Taysha Gene Therapies, Inc. | 1.93B | -4.01% | 706,850 | 7.47M |
| 106 | NTLA | Intellia Therapeutics, Inc. | 1.92B | -0.69% | 1,510,017 | 67.67M |
| 107 | GLPG | Galapagos NV | 1.91B | -4.06% | 201,480 | 1.31B |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 1.89B | -10.40% | 1,229,996 | 283.06M |
| 109 | ANAB | AnaptysBio, Inc. | 1.87B | -3.47% | 179,048 | 234.60M |
| 110 | VCEL | Vericel Corporation | 1.85B | -1.11% | 356,196 | 292.09M |
| 111 | GENB | Generate Biomedicines, Inc. | 1.85B | -5.16% | 87,775 | 31.89M |
| 112 | OCS | Oculis Holding AG | 1.84B | 5.24% | 332,649 | 1.51M |
| 113 | RAPP | Rapport Therapeutics, Inc. | 1.83B | 3.21% | 140,066 | - |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -1.07% | 227,212 | 217.17M |
| 115 | VRDN | Viridian Therapeutics, Inc. | 1.79B | -0.74% | 5,507,000 | 70.92M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -1.46% | 4,417,983 | 66.41M |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.77B | -6.62% | 939,690 | 899.11M |
| 118 | NUVB | Nuvation Bio Inc. | 1.73B | -1.19% | 1,644,149 | 143.05M |
| 119 | ARDX | Ardelyx, Inc. | 1.72B | -2.11% | 1,383,609 | 427.68M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -2.49% | 114,223 | 71.78M |
| 121 | PVLA | Palvella Therapeutics, Inc. | 1.67B | -10.62% | 236,326 | - |
| 122 | INVA | Innoviva, Inc. | 1.66B | -0.31% | 321,171 | 420.69M |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 2.02% | 7,370 | 66.05M |
| 124 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | -2.94% | 10,703 | 42.95M |
| 125 | IMCR | Immunocore Holdings plc | 1.57B | 0.29% | 111,981 | 412.81M |
| 126 | VIR | Vir Biotechnology, Inc. | 1.55B | -6.61% | 905,742 | 68.56M |
| 127 | NVAX | Novavax, Inc. | 1.55B | 0.53% | 4,922,889 | 596.34M |
| 128 | MBX | MBX Biosciences, Inc. | 1.53B | 0.40% | 308,976 | - |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.53B | 2.63% | 1,293,806 | - |
| 130 | FTRE | Fortrea Holdings Inc. | 1.53B | 3.26% | 560,625 | 2.71B |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.52B | -2.65% | 95,295 | - |
| 132 | IMTX | Immatics N.V. | 1.51B | -1.91% | 170,050 | 56.67M |
| 133 | PGEN | Precigen, Inc. | 1.50B | -3.64% | 930,257 | 9.68M |
| 134 | ATAI | AtaiBeckley Inc. | 1.48B | -3.12% | 1,526,445 | 4.09M |
| 135 | BHVN | Biohaven Ltd. | 1.48B | -2.09% | 11,651 | - |
| 136 | ABCL | AbCellera Biologics Inc. | 1.48B | -3.27% | 4,739,689 | 75.13M |
| 137 | IOVA | Iovance Biotherapeutics, Inc. | 1.46B | -13.20% | 26,972,695 | 263.50M |
| 138 | QURE | uniQure N.V. | 1.46B | 1.36% | 509,111 | 18.09M |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.43B | -2.23% | 104,435 | 2.50M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.38B | -1.51% | 1,326,259 | 71.80M |
| 141 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.02% | 356,670 | 73.62M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -2.40% | 79,675 | - |
| 143 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | -0.46% | 332,317 | - |
| 144 | MPLT | MapLight Therapeutics, Inc. | 1.31B | -0.41% | 38,683 | - |
| 145 | SVRA | Savara Inc. | 1.31B | -2.09% | 268,679 | - |
| 146 | GHRS | GH Research PLC | 1.30B | -6.42% | 61,328 | - |
| 147 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -3.56% | 471,907 | - |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.23B | -3.33% | 302,462 | - |
| 149 | URGN | UroGen Pharma Ltd. | 1.20B | -5.87% | 453,648 | 140.49M |
| 150 | DBVT | DBV Technologies S.A. | 1.20B | -1.19% | 66,104 | 5.74M |
| 151 | JBIO | Jade Biosciences, Inc. | 1.19B | -3.70% | 43,792 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -6.48% | 117,700 | 10.00M |
| 153 | PHAR | Pharming Group N.V. | 1.16B | -25.30% | 66,907 | 369.49M |
| 154 | EYPT | EyePoint, Inc. | 1.15B | 2.70% | 247,084 | 7.61M |
| 155 | MNKD | MannKind Corporation | 1.12B | 1.83% | 7,365,679 | 360.78M |
| 156 | IVA | Inventiva S.A. | 1.11B | -0.56% | 62,479 | 7.94M |
| 157 | SEPN | Septerna, Inc. | 1.10B | -0.65% | 48,447 | 45.95M |
| 158 | AVLN | Avalyn Pharma Inc. | 1.09B | -5.70% | 140,742 | - |
| 159 | COAG | Hemab Therapeutics Holdings, Inc. | 1.09B | -1.34% | 29,464 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 1.09B | -1.95% | 36,425 | 6.50M |
| 161 | OMER | Omeros Corporation | 1.07B | 0.13% | 190,914 | - |
| 162 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.01B | -1.02% | 958,788 | 185.74M |
| 163 | SANA | Sana Biotechnology, Inc. | 999.00M | -1.10% | 611,525 | - |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 959.52M | -4.66% | 129,418 | 204.89M |
| 165 | XNCR | Xencor, Inc. | 952.54M | -1.23% | 202,558 | 97.36M |
| 166 | ABSI | Absci Corporation | 919.47M | -0.59% | 2,315,063 | 2.80M |
| 167 | GERN | Geron Corporation | 916.49M | -9.49% | 6,457,005 | 196.12M |
| 168 | SLS | SELLAS Life Sciences Group, Inc. | 915.28M | -3.69% | 1,722,731 | - |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 913.54M | -5.11% | 559,742 | - |
| 170 | LBRX | LB Pharmaceuticals Inc | 898.41M | -2.09% | 11,619 | - |
| 171 | CGEM | Cullinan Therapeutics, Inc. | 894.73M | -2.87% | 141,885 | - |
| 172 | SPRY | ARS Pharmaceuticals, Inc. | 894.67M | -2.91% | 375,236 | 84.28M |
| 173 | MGTX | MeiraGTx Holdings plc | 893.18M | -2.53% | 90,029 | 81.39M |
| 174 | JANX | Janux Therapeutics, Inc. | 893.09M | 0.21% | 143,962 | 10.00M |
| 175 | DSGN | Design Therapeutics, Inc. | 885.33M | -2.58% | 89,425 | - |
| 176 | VOR | Vor Biopharma Inc. | 882.14M | 2.39% | 286,751 | - |
| 177 | ANNX | Annexon, Inc. | 875.10M | -5.53% | 927,824 | - |
| 178 | DRUG | Bright Minds Biosciences Inc. | 874.60M | 0.48% | 62,793 | - |
| 179 | TBPH | Theravance Biopharma, Inc. | 869.83M | -0.32% | 56,657 | 109.78M |
| 180 | CTMX | CytomX Therapeutics, Inc. | 864.24M | -3.87% | 1,094,672 | 76.20M |
| 181 | ABUS | Arbutus Biopharma Corporation | 856.69M | -1.58% | 169,147 | 14.08M |
| 182 | ANRO | Alto Neuroscience, Inc. | 828.30M | -3.51% | 72,718 | - |
| 183 | SPTX | Seaport Therapeutics, Inc. | 827.23M | -2.50% | 122,822 | - |
| 184 | KURA | Kura Oncology, Inc. | 825.49M | -2.72% | 187,262 | 67.48M |
| 185 | SGP | SpyGlass Pharma, Inc. | 821.96M | -1.86% | 17,492 | - |
| 186 | EVMN | Evommune, Inc. | 821.58M | -4.28% | 75,274 | 13.00M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 795.05M | -3.56% | 186,939 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 785.99M | -1.08% | 1,711,882 | 22.00K |
| 189 | GYRE | Gyre Therapeutics, Inc. | 702.24M | -9.95% | 2,204 | 117.05M |
| 190 | TENX | Tenax Therapeutics, Inc. | 694.76M | -1.83% | 184,169 | - |
| 191 | DRTS | Alpha Tau Medical Ltd. | 690.88M | 3.43% | 275,073 | - |
| 192 | SLDB | Solid Biosciences Inc. | 685.94M | -3.19% | 183,118 | - |
| 193 | LXRX | Lexicon Pharmaceuticals, Inc. | 658.82M | -2.81% | 3,036,311 | 49.80M |
| 194 | CABA | Cabaletta Bio, Inc. | 655.46M | 7.77% | 2,238,137 | - |
| 195 | ARVN | Arvinas, Inc. | 652.40M | -0.58% | 321,629 | 262.60M |
| 196 | ACRS | Aclaris Therapeutics, Inc. | 649.44M | -2.72% | 292,447 | 7.83M |
| 197 | FBRX | Forte Biosciences, Inc. | 642.31M | -1.06% | 27,084 | - |
| 198 | TRAX | First Tracks Biotherapeutics, Inc. | 639.38M | -9.14% | 183,204 | - |
| 199 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 636.26M | -4.56% | 86,745 | - |
| 200 | STRO | Sutro Biopharma, Inc. | 629.00M | 0.73% | 65,590 | 102.48M |
| 201 | CRMD | CorMedix Inc. | 621.93M | -1.49% | 237,892 | 311.71M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 612.43M | -7.91% | 1,063,873 | 122.29M |
| 203 | CBIO | Crescent Biopharma, Inc. | 608.42M | 1.38% | 1,883 | 11.88M |
| 204 | AVTX | Avalo Therapeutics, Inc. | 605.08M | 3.85% | 2,013,243 | 59.00K |
| 205 | ALT | Altimmune, Inc. | 592.31M | -6.44% | 1,613,433 | 41.00K |
| 206 | PRME | Prime Medicine, Inc. | 588.12M | -2.64% | 911,292 | 4.03M |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 585.57M | -0.20% | 381,522 | 170.16M |
| 208 | PRTA | Prothena Corporation plc | 584.63M | -2.86% | 89,824 | 9.68M |
| 209 | AGMB | AgomAb Therapeutics NV | 581.62M | -3.51% | 2,228 | - |
| 210 | CADL | Candel Therapeutics, Inc. | 566.56M | 1.38% | 804,120 | - |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 565.35M | -1.37% | 157,611 | - |
| 212 | PROK | ProKidney Corp. | 564.67M | -4.59% | 172,299 | 893.00K |
| 213 | CLYM | Climb Bio, Inc. | 561.76M | -3.76% | 280,306 | - |
| 214 | ANL | Adlai Nortye Ltd. | 560.00M | -1.89% | 44,659 | 5.00M |
| 215 | MDXG | MiMedx Group, Inc. | 548.12M | 0.55% | 240,997 | 389.42M |
| 216 | CTNM | Contineum Therapeutics, Inc. | 542.12M | -2.81% | 41,199 | - |
| 217 | TECX | Tectonic Therapeutic, Inc. | 536.05M | -2.00% | 20,568 | - |
| 218 | FDMT | 4D Molecular Therapeutics, Inc. | 527.97M | -3.07% | 257,164 | 85.21M |
| 219 | AURA | Aura Biosciences, Inc. | 523.23M | -1.69% | 111,997 | - |
| 220 | VALN | Valneva SE | 516.63M | 5.36% | 310 | 205.07M |
| 221 | RGNX | REGENXBIO Inc. | 516.17M | -2.15% | 358,760 | 170.44M |
| 222 | PRLD | Prelude Therapeutics Incorporated | 515.83M | 5.99% | 163,615 | 12.14M |
| 223 | IMMX | Immix Biopharma, Inc. | 514.22M | -6.01% | 250,868 | - |
| 224 | VSTM | Verastem, Inc. | 513.00M | -2.83% | 477,406 | 30.91M |
| 225 | EIKN | Eikon Therapeutics, Inc. | 504.57M | -6.52% | 1,382 | - |
| 226 | ASMB | Assembly Biosciences, Inc. | 500.62M | 0.45% | 1,441 | 72.30M |
| 227 | XOMA | XOMA Royalty Corporation | 491.64M | -0.82% | 59,966 | 52.15M |
| 228 | OCGN | Ocugen, Inc. | 490.85M | -0.34% | 7,811,554 | 4.47M |
| 229 | UPB | Upstream Bio, Inc. | 487.60M | -2.50% | 46,274 | 2.85M |
| 230 | RIGL | Rigel Pharmaceuticals, Inc. | 486.60M | -1.39% | 81,859 | 299.77M |
| 231 | SGMT | Sagimet Biosciences Inc. | 485.99M | -6.09% | 414,157 | - |
| 232 | NGNE | Neurogene Inc. | 485.42M | -3.85% | 2,167 | 925.00K |
| 233 | ADCT | ADC Therapeutics SA | 479.51M | -2.33% | 285,125 | 79.18M |
| 234 | LYEL | Lyell Immunopharma, Inc. | 473.07M | -2.76% | 13,633 | 36.00K |
| 235 | OVID | Ovid Therapeutics Inc. | 472.39M | -1.80% | 458,977 | 7.25M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.01M | 0.66% | 27,034 | - |
| 237 | FULC | Fulcrum Therapeutics, Inc. | 467.77M | -1.27% | 95,671 | 80.00M |
| 238 | STTK | Shattuck Labs, Inc. | 461.80M | -8.53% | 188,263 | 1.00M |
| 239 | LXEO | Lexeo Therapeutics, Inc. | 448.97M | -2.73% | 8,273 | - |
| 240 | AVIR | Atea Pharmaceuticals, Inc. | 440.15M | -2.65% | 50,479 | - |
| 241 | ENTA | Enanta Pharmaceuticals, Inc. | 437.47M | -1.08% | 74,106 | 66.98M |
| 242 | ZURA | Zura Bio Limited | 433.60M | -6.54% | 231,132 | - |
| 243 | AUTL | Autolus Therapeutics plc | 428.49M | -5.29% | 618,322 | 75.39M |
| 244 | PRTC | PureTech Health plc | 425.06M | 2.32% | 29,560 | 4.66M |
| 245 | BNTC | Benitec Biopharma Inc. | 422.19M | -1.95% | 16,507 | - |
| 246 | LRMR | Larimar Therapeutics, Inc. | 414.49M | -3.86% | 509,859 | - |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 412.13M | -2.20% | 614,548 | - |
| 248 | IPSC | Century Therapeutics, Inc. | 410.31M | -2.78% | 188,601 | 109.16M |
| 249 | IVVD | Invivyd, Inc. | 408.65M | -1.03% | 580,505 | 53.43M |
| 250 | MNPR | Monopar Therapeutics Inc. | 405.95M | -5.01% | 114,622 | - |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 403.51M | -9.81% | 942,203 | 217.78M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 390.95M | -1.83% | 6,436 | 9.01M |
| 253 | VTVT | vTv Therapeutics Inc. | 385.81M | -1.86% | 963 | 17.00K |
| 254 | SRZN | Surrozen, Inc. | 378.26M | -3.52% | 261 | 7.49M |
| 255 | NAUT | Nautilus Biotechnology, Inc. | 369.80M | -1.02% | 67,599 | - |
| 256 | YDES | YD Bio Limited | 369.18M | 1.08% | 964 | 510.36K |
| 257 | IRD | Opus Genetics, Inc. | 362.72M | -3.42% | 134,781 | 14.20M |
| 258 | PBYI | Puma Biotechnology, Inc. | 362.35M | -4.43% | 112,668 | 228.37M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 359.90M | -15.45% | 1,325,494 | - |
| 260 | LCTX | Lineage Cell Therapeutics, Inc. | 352.46M | -1.05% | 351,328 | 14.56M |
| 261 | BCYC | Bicycle Therapeutics plc | 343.66M | -4.27% | 149,474 | 63.50M |
| 262 | NAGE | Niagen Bioscience, Inc. | 335.03M | -16.00% | 1,301,264 | 130.42M |
| 263 | IKT | Inhibikase Therapeutics, Inc. | 334.09M | -2.49% | 113,611 | 1.00 |
| 264 | IMRX | Immuneering Corporation | 331.57M | -1.25% | 11,093 | - |
| 265 | ARMP | Armata Pharmaceuticals, Inc. | 326.95M | -1.66% | 53,041 | 4.90M |
| 266 | ABEO | Abeona Therapeutics Inc. | 325.94M | -4.66% | 611,332 | 5.82M |
| 267 | PALI | Palisade Bio, Inc. | 325.64M | -2.75% | 363,352 | - |
| 268 | SLN | Silence Therapeutics plc | 324.02M | -6.79% | 21,863 | 559.00K |
| 269 | CMPX | Compass Therapeutics, Inc. | 323.26M | -4.01% | 2,566,915 | 850.00K |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 322.22M | -8.28% | 119,526 | - |
| 271 | GLSI | Greenwich LifeSciences, Inc. | 322.12M | 0.82% | 14,805 | - |
| 272 | NGEN | NervGen Pharma Corp. | 316.84M | 0.64% | 114 | - |
| 273 | RZLT | Rezolute, Inc. | 316.81M | -2.87% | 228,078 | - |
| 274 | ZNTL | Zentalis Pharmaceuticals, Inc. | 302.88M | 2.15% | 185,758 | 26.87M |
| 275 | ARTV | Artiva Biotherapeutics, Inc. | 301.54M | -1.53% | 46,423 | 251.00K |
| 276 | LENZ | LENZ Therapeutics, Inc. | 300.38M | -1.03% | 132,118 | 19.09M |
| 277 | AVXL | Anavex Life Sciences Corp. | 299.33M | -3.29% | 481,579 | - |
| 278 | ACIU | AC Immune SA | 297.60M | 1.01% | 62,602 | 4.62M |
| 279 | TARA | Protara Therapeutics, Inc. | 296.50M | -4.86% | 158,657 | - |
| 280 | EDIT | Editas Medicine, Inc. | 295.68M | -4.88% | 705,880 | 38.69M |
| 281 | CCCC | C4 Therapeutics, Inc. | 290.78M | 1.71% | 1,239,525 | 35.95M |
| 282 | ELDN | Eledon Pharmaceuticals, Inc. | 288.29M | -0.13% | 531,254 | - |
| 283 | CLLS | Cellectis S.A. | 282.89M | -1.77% | 607 | 79.59M |
| 284 | ALEC | Alector, Inc. | 278.12M | -2.53% | 79,559 | 21.05M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 274.08M | 2.63% | 1,346,581 | 114.70K |
| 286 | CGEN | Compugen Ltd. | 273.26M | 4.71% | 167,979 | 72.76M |
| 287 | REPL | Replimune Group, Inc. | 271.25M | -4.51% | 1,163,077 | - |
| 288 | NVCT | Nuvectis Pharma, Inc. | 271.09M | 2.20% | 52,213 | - |
| 289 | FATE | Fate Therapeutics, Inc. | 270.94M | 1.75% | 1,788,188 | 6.65M |
| 290 | HELP | Cybin Inc. | 270.19M | -2.53% | 14,436 | - |
| 291 | NERV | Minerva Neurosciences, Inc. | 268.75M | -1.61% | 19,558 | - |
| 292 | CHRS | Coherus Oncology, Inc. | 266.80M | -1.14% | 323,215 | 42.17M |
| 293 | TRDA | Entrada Therapeutics, Inc. | 263.06M | -55.08% | 2,609,957 | 5.74M |
| 294 | ALXO | ALX Oncology Holdings Inc. | 258.36M | -8.13% | 287,894 | - |
| 295 | FHTX | Foghorn Therapeutics Inc. | 254.47M | -7.37% | 46,599 | 30.91M |
| 296 | NBP | NovaBridge Biosciences | 254.43M | -2.22% | 394,574 | - |
| 297 | ACHV | Achieve Life Sciences, Inc. | 252.36M | -1.25% | 350,344 | - |
| 298 | ARCT | Arcturus Therapeutics Holdings Inc. | 251.26M | -3.18% | 227,884 | 82.03M |
| 299 | CDXS | Codexis, Inc. | 244.44M | 1.13% | 351,855 | 70.39M |
| 300 | VYGR | Voyager Therapeutics, Inc. | 241.37M | -4.20% | 170,369 | 40.37M |
| 301 | HUMA | Humacyte, Inc. | 239.78M | 9.83% | 6,110,670 | 2.04M |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 237.61M | -3.03% | 3,095 | 1.78M |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 236.74M | -5.01% | 4,786 | 44.64M |
| 304 | ADAG | Adagene Inc. | 236.21M | -0.97% | 1,187 | 7.67M |
| 305 | MIST | Milestone Pharmaceuticals Inc. | 234.87M | -2.79% | 703,447 | 1.55M |
| 306 | HRTX | Heron Therapeutics, Inc. | 232.03M | -6.11% | 567,109 | 154.90M |
| 307 | KROS | Keros Therapeutics, Inc. | 231.52M | -0.68% | 37,975 | 244.06M |
| 308 | OBIO | Orchestra BioMed Holdings, Inc. | 230.86M | -4.01% | 43,822 | 33.48M |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 228.93M | -1.92% | 68 | 19.39M |
| 310 | NKTX | Nkarta, Inc. | 227.42M | -3.92% | 329,952 | - |
| 311 | CAMP | Camp4 Therapeutics Corporation | 225.88M | 7.14% | 553 | 3.50M |
| 312 | MDWD | MediWound Ltd. | 223.44M | 0.09% | 26,968 | 16.96M |
| 313 | CNTX | Context Therapeutics Inc. | 216.83M | -2.07% | 94,357 | - |
| 314 | OABI | OmniAb, Inc. | 206.32M | -0.35% | 47,884 | 18.67M |
| 315 | TNXP | Tonix Pharmaceuticals Holding Corp. | 204.84M | -1.84% | 151,732 | 13.11M |
| 316 | UNCY | Unicycive Therapeutics, Inc. | 200.89M | -2.09% | 283,418 | - |
| 317 | WHWK | Whitehawk Therapeutics, Inc. | 200.18M | -2.41% | 4,986 | 7.15M |
| 318 | RNA | Atrium Therapeutics, Inc. | 199.99M | -1.53% | 1,474 | 18.62M |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 197.48M | -2.88% | 32,478 | 146.07M |
| 320 | ENLV | Enlivex Ltd. | 196.00M | -2.39% | 72,333 | - |
| 321 | KRRO | Korro Bio, Inc. | 194.99M | 1.35% | 26,132 | 6.39M |
| 322 | IFRX | InflaRx N.V. | 193.74M | 7.20% | 3,747,010 | 33.82K |
| 323 | DTIL | Precision BioSciences, Inc. | 192.75M | -0.66% | 48,312 | 45.07M |
| 324 | MGNX | MacroGenics, Inc. | 188.14M | -1.66% | 155,984 | 149.50M |
| 325 | CRBU | Caribou Biosciences, Inc. | 187.67M | -2.05% | 495,915 | 11.16M |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 186.41M | -3.75% | 107,846 | - |
| 327 | ELTX | Elicio Therapeutics, Inc. | 186.17M | -3.16% | 238 | - |
| 328 | TLSA | Tiziana Life Sciences Ltd | 181.86M | -3.06% | 300 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 177.68M | -4.28% | 89,641 | - |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 177.01M | 3.23% | 2,264,932 | 225.00K |
| 331 | CNTN | Canton Strategic Holdings, Inc. | 173.37M | -4.38% | 211,253 | - |
| 332 | PLYX | Polaryx Therapeutics, Inc. | 173.28M | -3.68% | 289 | - |
| 333 | PRQR | ProQR Therapeutics N.V. | 170.68M | -5.81% | 234,914 | 19.19M |
| 334 | ANTX | AN2 Therapeutics, Inc. | 168.10M | 0.43% | 34,901 | - |
| 335 | MENS | Jyong Biotech Ltd. | 165.34M | - | 17,969 | - |
| 336 | OKUR | OnKure Therapeutics, Inc. | 161.18M | -1.97% | 2,194 | - |
| 337 | NTHI | NeOnc Technologies Holdings, Inc. | 157.68M | 17.89% | 92,388 | 39.99K |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 157.52M | -3.22% | 3,259 | 52.74M |
| 339 | MOLN | Molecular Partners AG | 157.48M | 4.07% | 271 | 856.30K |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 156.93M | -1.02% | 39,090 | 2.00M |
| 341 | SPRB | Spruce Biosciences, Inc. | 154.54M | -1.18% | 5,298 | 697.00K |
| 342 | KZIA | Kazia Therapeutics Limited | 153.35M | -3.03% | 20,010 | 1.27M |
| 343 | HURA | TuHURA Biosciences, Inc. | 151.95M | -5.91% | 367,620 | - |
| 344 | EDSA | Edesa Biotech, Inc. | 149.37M | 12.14% | 209,253 | - |
| 345 | SPRO | Spero Therapeutics, Inc. | 147.94M | 0.99% | 183,529 | 66.80M |
| 346 | IMUX | Immunic, Inc. | 147.15M | -1.81% | 166,538 | - |
| 347 | BDTX | Black Diamond Therapeutics, Inc. | 146.66M | -9.22% | 670,910 | 70.00M |
| 348 | PYXS | Pyxis Oncology, Inc. | 145.77M | 0.87% | 435,781 | 13.86M |
| 349 | AGEN | Agenus Inc. | 142.07M | -4.88% | 383,745 | 114.20M |
| 350 | IPHA | Innate Pharma S.A. | 139.82M | -6.62% | 442 | 10.57M |
| 351 | ALPS | Alps Group Inc | 139.36M | 1.77% | 10,031 | 3.74M |
| 352 | ACOG | Alpha Cognition Inc. | 138.27M | -0.47% | 3,238 | 10.22M |
| 353 | VRCA | Verrica Pharmaceuticals Inc. | 138.03M | -4.69% | 22,474 | 35.58M |
| 354 | GALT | Galectin Therapeutics Inc. | 134.29M | -9.33% | 296,215 | - |
| 355 | CNTB | Connect Biopharma Holdings Limited | 133.39M | -4.84% | 59,682 | 64.00K |
| 356 | EQ | Equillium, Inc. | 132.14M | -3.69% | 23,414 | 4.39M |
| 357 | ENGN | enGene Therapeutics Inc. | 124.27M | -79.04% | 13,412,979 | - |
| 358 | GNLX | Genelux Corporation | 123.80M | -2.79% | 103,717 | 8.00K |
| 359 | AARD | Aardvark Therapeutics, Inc. | 121.95M | -5.09% | 1,497 | - |
| 360 | PEPG | PepGen Inc. | 121.74M | -4.61% | 112,728 | - |
| 361 | CBUS | Cibus, Inc. | 119.76M | -1.26% | 133,345 | 3.64M |
| 362 | KLRS | Kalaris Therapeutics, Inc. | 116.46M | 0.10% | 23,525 | - |
| 363 | BMEA | Biomea Fusion, Inc. | 116.40M | 0.63% | 359,393 | - |
| 364 | GUTS | Fractyl Health, Inc. | 115.34M | -1.12% | 688,646 | 3.00K |
| 365 | TTRX | Turn Therapeutics Inc. | 114.62M | 1.40% | 70 | - |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 112.25M | 10.48% | 5,381,098 | 65.34K |
| 367 | CRDF | Cardiff Oncology, Inc. | 111.78M | -2.68% | 148,923 | 593.00K |
| 368 | CUE | Cue Biopharma, Inc. | 110.68M | 0.06% | 269,142 | 27.47M |
| 369 | SEER | Seer, Inc. | 106.92M | 0.26% | 2,168 | 16.58M |
| 370 | ALDX | Aldeyra Therapeutics, Inc. | 103.75M | -1.15% | 304,739 | - |
| 371 | ONCY | Oncolytics Biotech Inc. | 103.70M | -2.93% | 463,071 | - |
| 372 | CGTX | Cognition Therapeutics, Inc. | 102.76M | -6.50% | 447,248 | - |
| 373 | VANI | Vivani Medical, Inc. | 102.42M | -3.20% | 1,465 | - |
| 374 | ANIX | Anixa Biosciences, Inc. | 101.59M | -0.98% | 40,416 | - |
| 375 | NRXP | NRx Pharmaceuticals, Inc. | 100.59M | -0.16% | 341,145 | 1.23M |
| 376 | NRXS | NeurAxis, Inc. | 98.72M | -2.61% | 47,580 | 3.57M |
| 377 | COYA | Coya Therapeutics, Inc. | 97.58M | -1.89% | 2,295 | 7.95M |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 94.87M | -1.00% | 136,983 | 1.63M |
| 379 | ATYR | aTyr Pharma, Inc. | 94.39M | -7.43% | 419,518 | 190.00K |
| 380 | QTTB | Q32 Bio Inc. | 93.77M | 1.10% | 92,748 | 53.74M |
| 381 | ACET | Adicet Bio, Inc. | 92.01M | 0.12% | 30,937 | - |
| 382 | LONA | LeonaBio, Inc. | 91.59M | 3.50% | 17,293 | - |
| 383 | PMN | ProMIS Neurosciences, Inc. | 90.57M | -8.18% | 38,704 | - |
| 384 | RNTX | Rein Therapeutics Inc. | 90.14M | -1.28% | 213,801 | - |
| 385 | EXOZ | eXoZymes, Inc. | 89.03M | -0.38% | 439 | -700.00 |
| 386 | OKYO | OKYO Pharma Limited | 86.85M | -1.49% | 21,398 | - |
| 387 | PYPD | PolyPid Ltd. | 85.49M | - | 6,310 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 84.96M | 1.28% | 3,753 | 16.80M |
| 389 | FBIO | Fortress Biotech, Inc. | 82.02M | -3.18% | 78,236 | 63.26M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 81.91M | - | 100,593 | - |
| 391 | CSBR | Champions Oncology, Inc. | 81.45M | -1.92% | 2,490 | 57.95M |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 80.20M | -0.96% | 231,582 | - |
| 393 | GANX | Gain Therapeutics, Inc. | 79.34M | -2.62% | 149,383 | - |
| 394 | GOSS | Gossamer Bio, Inc. | 79.33M | -3.48% | 1,441,661 | 48.47M |
| 395 | KALA | KALA BIO, Inc. | 79.01M | -26.15% | 5,317,707 | - |
| 396 | ANVS | Annovis Bio, Inc. | 78.73M | -5.00% | 365,823 | - |
| 397 | ICCC | ImmuCell Corporation | 78.71M | 0.46% | 7,319 | 27.64M |
| 398 | ATHE | Alterity Therapeutics Limited | 78.70M | 0.44% | 14,359 | 4.43M |
| 399 | ACTU | Actuate Therapeutics, Inc. | 78.01M | 10.03% | 61,947 | - |
| 400 | RLYB | Rallybio Corporation | 77.52M | 0.65% | 41,465 | 858.00K |
| 401 | XBIT | XBiotech Inc. | 77.44M | -0.39% | 18,729 | - |
| 402 | PLRX | Pliant Therapeutics, Inc. | 75.54M | -0.81% | 359,141 | - |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 75.19M | -2.76% | 111,006 | - |
| 404 | MCRB | Seres Therapeutics, Inc. | 74.94M | -2.75% | 21,326 | 1.15M |
| 405 | TCRX | TScan Therapeutics, Inc. | 70.92M | -5.60% | 395,302 | 9.14M |
| 406 | OSTX | OS Therapies Incorporated | 70.83M | -2.60% | 167,535 | - |
| 407 | MNOV | MediciNova, Inc. | 70.39M | -1.38% | 3,290 | 409.66K |
| 408 | IBO | Impact BioMedical Inc. | 67.40M | -1.56% | 33,687 | 32.00K |
| 409 | IMA | ImageneBio, Inc. | 67.11M | -1.32% | 3,324 | 800.00K |
| 410 | FLNA | Filana Therapeutics, Inc. | 66.18M | -4.86% | 250,134 | - |
| 411 | PDSB | PDS Biotechnology Corporation | 65.30M | 10.38% | 364,676 | - |
| 412 | ATRA | Atara Biotherapeutics, Inc. | 65.03M | 48.35% | 38,685,293 | 120.77M |
| 413 | CING | Cingulate Inc. | 63.95M | -2.06% | 311,140 | - |
| 414 | ENTX | Entera Bio Ltd. | 62.94M | 8.00% | 91,405 | 42.00K |
| 415 | IMMP | Immutep Limited | 62.92M | -2.49% | 608,806 | 5.28M |
| 416 | BYSI | BeyondSpring Inc. | 61.68M | -3.23% | 5,050 | 1.88M |
| 417 | HYFT | MindWalk Holdings Corp. | 61.59M | -2.36% | 8,616 | 20.70M |
| 418 | IBIO | iBio, Inc. | 61.26M | -4.24% | 102,219 | 300.00K |
| 419 | ESLA | Estrella Immunopharma, Inc. | 57.60M | 3.85% | 5,471 | - |
| 420 | INKT | MiNK Therapeutics, Inc. | 55.52M | -0.27% | 4,577 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 54.67M | 0.27% | 75 | - |
| 422 | DWTX | Dogwood Therapeutics, Inc. | 54.11M | -1.82% | 56,650 | - |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 53.46M | -0.69% | 86,744 | 25.21M |
| 424 | TIL | Instil Bio, Inc. | 53.34M | -1.81% | 7,459 | - |
| 425 | LIXT | Lixte Biotechnology Holdings, Inc. | 49.96M | -2.27% | 57,960 | - |
| 426 | ATOS | Atossa Therapeutics, Inc. | 49.17M | -1.55% | 11,421 | - |
| 427 | RADX | Radiopharm Theranostics Limited | 48.73M | -2.35% | 15,049 | 10.86M |
| 428 | XLO | Xilio Therapeutics, Inc. | 47.71M | 0.95% | 1,739 | 43.77M |
| 429 | NTRB | Nutriband Inc. | 47.04M | -2.52% | 1,691 | 2.04M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 45.55M | -1.12% | 27,194 | - |
| 431 | LITS | Lite Strategy, Inc. | 42.73M | -1.26% | 155,516 | - |
| 432 | DARE | Daré Bioscience, Inc. | 41.93M | -8.86% | 350,033 | 1.03M |
| 433 | PSTV | Plus Therapeutics, Inc. | 41.79M | 1.50% | 77,682 | 5.21M |
| 434 | HYPD | Hyperion DeFi, Inc. | 41.58M | 0.27% | 4,895 | 813.46K |
| 435 | RNXT | RenovoRx, Inc. | 41.27M | 2.93% | 67,282 | 1.12M |
| 436 | INMB | INmune Bio Inc. | 39.08M | -3.29% | 161,725 | 50.00K |
| 437 | ATNM | Actinium Pharmaceuticals, Inc. | 38.40M | -0.66% | 103 | 90.00K |
| 438 | ALGS | Aligos Therapeutics, Inc. | 38.36M | -2.67% | 31,499 | 2.19M |
| 439 | MREO | Mereo BioPharma Group plc | 37.43M | -1.14% | 1,361,511 | 500.00K |
| 440 | NXTC | NextCure, Inc. | 37.19M | -3.82% | 360 | - |
| 441 | PTN | Palatin Technologies, Inc. | 37.00M | 4.21% | 2,760 | 8.96M |
| 442 | VERU | Veru Inc. | 36.59M | 2.70% | 1 | 16.89M |
| 443 | BOLD | Boundless Bio, Inc. | 34.97M | -1.27% | 43,384 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 34.95M | 1.78% | 7,806 | - |
| 445 | CRVO | CervoMed Inc. | 34.72M | -2.09% | 33,934 | 4.01M |
| 446 | GRCE | Grace Therapeutics, Inc. | 34.66M | -5.49% | 155,361 | - |
| 447 | SNSE | Sensei Biotherapeutics, Inc. | 34.58M | -0.85% | 6,418 | - |
| 448 | APLM | Apollomics, Inc. | 34.04M | 1.71% | 915 | 8.84M |
| 449 | PLUR | Pluri Inc. | 33.67M | 1.52% | 1,115 | 1.34M |
| 450 | EVAX | Evaxion A/S | 32.78M | -10.88% | 26,892 | 7.53M |
| 451 | IGC | IGC Pharma, Inc. | 31.80M | 1.16% | 124,876 | 1.11M |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 31.77M | 5.00% | 101,996 | 22.00K |
| 453 | SKYE | Skye Bioscience, Inc. | 31.26M | 4.58% | 145,632 | - |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 31.11M | -1.98% | 22,079 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 31.02M | -1.35% | 802 | - |
| 456 | HOWL | Werewolf Therapeutics, Inc. | 30.66M | -2.95% | 341,788 | 1.14M |
| 457 | NNVC | NanoViricides, Inc. | 30.23M | -4.11% | 944 | - |
| 458 | BCTX | BriaCell Therapeutics Corp. | 29.97M | 0.97% | 489 | - |
| 459 | TVGN | Tevogen Bio Holdings Inc. | 29.57M | 0.42% | 401 | - |
| 460 | LSTA | Lisata Therapeutics, Inc. | 29.31M | -0.46% | 3,593 | 170.00K |
| 461 | KYNB | Kyntra Bio, Inc. | 29.15M | 1.12% | 100 | 6.44M |
| 462 | TPST | Tempest Therapeutics, Inc. | 29.12M | 0.50% | 34,905 | - |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 28.97M | -0.13% | 204 | 14.99M |
| 464 | ABVC | ABVC BioPharma, Inc. | 27.45M | 0.99% | 23 | 797.92K |
| 465 | SER | Serina Therapeutics, Inc. | 27.41M | 0.55% | 3,914 | 130.00K |
| 466 | DYAI | Dyadic International, Inc. | 27.24M | -1.66% | 6,470 | 3.09M |
| 467 | PLRZ | Polyrizon Ltd. | 27.05M | 0.80% | 3,766 | - |
| 468 | CELU | Celularity Inc. | 26.82M | - | 3 | 26.55M |
| 469 | BRNS | Barinthus Biotherapeutics plc | 26.14M | -2.66% | 3,162 | 14.97M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 25.95M | -2.10% | 60,559 | - |
| 471 | LGVN | Longeveron Inc. | 25.47M | -0.46% | 89,279 | 1.20M |
| 472 | MRKR | Marker Therapeutics, Inc. | 24.01M | -1.37% | 38,957 | 3.55M |
| 473 | CRIS | Curis, Inc. | 23.99M | -2.72% | 62,719 | 9.44M |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 23.68M | -2.10% | 124,428 | 789.00K |
| 475 | LTRN | Lantern Pharma Inc. | 23.54M | -1.87% | 36,377 | - |
| 476 | AEON | AEON Biopharma, Inc. | 23.45M | 2.34% | 13,983 | - |
| 477 | OSRH | OSR Holdings, Inc. | 23.18M | 19.85% | 4,030,427 | 2.91M |
| 478 | OTLK | Outlook Therapeutics, Inc. | 22.80M | -6.00% | 4,676,218 | 205.70K |
| 479 | ALLR | Allarity Therapeutics, Inc. | 22.73M | -0.68% | 102,704 | 320.00K |
| 480 | VYNE | VYNE Therapeutics Inc. | 22.54M | 1.03% | 100,412 | 570.00K |
| 481 | XCUR | Exicure, Inc. | 21.61M | - | 188 | 500.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 21.13M | -0.29% | 22,727 | - |
| 483 | QNCX | Quince Therapeutics, Inc. | 20.95M | 5.33% | 332,025 | - |
| 484 | ICU | SeaStar Medical Holding Corporation | 19.77M | 1.64% | 48,211 | 1.23M |
| 485 | COCP | Cocrystal Pharma, Inc. | 19.37M | -0.35% | 43,986 | - |
| 486 | LPCN | Lipocine Inc. | 19.26M | -1.23% | 19,712 | 1.98M |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 18.90M | -0.49% | 32,931 | - |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 17.37M | -3.86% | 399,869 | 3.94M |
| 489 | TRAW | Traws Pharma, Inc. | 17.17M | -0.59% | 59,305 | 2.79M |
| 490 | GRDX | GridAI Technologies Corp. | 16.68M | 5.08% | 154,834 | - |
| 491 | TOVX | Theriva Biologics, Inc. | 16.15M | -7.91% | 1,453,601 | 300.00K |
| 492 | LEXX | Lexaria Bioscience Corp. | 16.11M | -3.62% | 110,634 | 368.00K |
| 493 | INAB | IN8bio, Inc. | 15.76M | 1.27% | 24,299 | - |
| 494 | GNTA | Genenta Science S.p.A. | 15.58M | -4.29% | 40,523 | - |
| 495 | HIND | Vyome Holdings, Inc. | 15.46M | 0.14% | 1 | 319.71K |
| 496 | NCEL | NewcelX Ltd. | 15.09M | -0.30% | 3,829 | - |
| 497 | CLRB | Cellectar Biosciences, Inc. | 14.63M | -2.27% | 324,197 | - |
| 498 | BLRX | BioLineRx Ltd. | 14.39M | -1.49% | 8,074 | 1.18M |
| 499 | HOTH | Hoth Therapeutics, Inc. | 13.81M | -2.34% | 201 | - |
| 500 | PASG | Passage Bio, Inc. | 13.70M | 3.64% | 114 | - |